[Laboratory monitoring of antithrombotic treatment].
A number of tests can be employed in monitoring anticoagulant, thrombolytic and antiaggregation treatment. Not all, however, indicate precisely the therapeutic effect of the drug used. Some of them are of linear character and they monitor closely the dosage, others have a series of non-specific reactions and the therapeutic effect is largely influenced by these circumstances. This article describes the individual monitoring systems, it deals with their potential reliability issues, and, also, treatment monitoring issues in various diagnostic environments are discussed.
Pecka
M
M
II. interní klinika Lékarské fakulty UK a FN, Hradec Králové. pecka@fnhk.cz
D000925:Anticoagulants / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D016903:Drug Monitoring; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors